Motivational readiness for treatment in weight control programs: The TREatment MOtivation and REadiness (TRE-MORE) test

被引:0
|
作者
B. Cresci
G. Castellini
L. Pala
C. Ravaldi
C. Faravelli
C. M. Rotella
V. Ricca
机构
[1] Section of Endocrinology,Department of Clinical Pathophysiology
[2] Obesity Agency,Department of Neuropsychiatry Science
[3] Psychiatry Unit,Department of Pathophysiology
[4] University of Florence,undefined
关键词
Motivation; overweight; readiness; treatment; weight loss;
D O I
暂无
中图分类号
学科分类号
摘要
Background and aims: The degree of motivation before starting the treatment represents a pre-treatment predictor of successful weight management. The aim of this study is to develop and validate a new self-reported questionnaire of motivation and readiness to change before starting a lifestyle modification program (the TREatment MOtivation and REadiness test) (TRE-MORE) for overweight patients. Methods and results: TRE-MORE was evaluated in a consecutive series of 129 obese patients attending our Outpatient Clinic. Validation of the questionnaire was performed through test-retest reliability, internal consistency, psycho-pathological correlates, and concurrent validity. Subjects have been evaluated by means of a clinical interview, and different self-reported questionnaires, assessing the eating specific and general psychopathology, and quality of life. TRE-MORE total and subscales scores showed good test-retest reliability and internal consistency. We identified 10 items grouped in 3 areas (obstacles and desire to overcome, taking care of themselves, and sharing the problems, current lifestyle). TRE-MORE scores were significantly correlated with eating specific psychopathology and quality of life measures. Univariate and Receiver Operating Characteristic curve analysis showed that TRE-MORE total and subscales scores represent a good model for predicting a weight loss >5% of the initial weight after 6 months of treatment. Conclusion: TRE-MORE represents a validated and easy-to-use questionnaire assessing at the meantime the treatment motivation and readiness with good predictive capacity for weight loss.
引用
收藏
页码:e70 / e77
相关论文
共 45 条
  • [41] Are individuals with loss-of-control eating more prone to dietary lapse in behavioural weight loss treatment? An ecological momentary assessment study
    Manasse, Stephanie M.
    Schumacher, Leah M.
    Goldstein, Stephanie P.
    Martin, Gerald J.
    Crosby, Ross D.
    Juarascio, Adrienne S.
    Butryn, Meghan L.
    Forman, Evan M.
    EUROPEAN EATING DISORDERS REVIEW, 2018, 26 (03) : 259 - 264
  • [42] One-Year Liraglutide Treatment Offers Greater Weight Reduction and More Improved Glycemic Control Compared with Sitagliptin, Both in Combination with Metformin
    Pratley, Richard
    Grimmeshave, Lise
    Xu, Yizhen
    Garber, Alan
    DIABETES, 2011, 60 : A615 - A615
  • [43] Initial Appropriate Empiric Therapy Plays More Important Role In Infection Control Compared With Adjusting Treatment Based On Microbiological Susceptibility Test Afterwards
    Du, W.
    Chen, H.
    Tang, W.
    Shi, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [44] Long-term treatment with GLP-1 analog liraglutide reduces body weight and improves glucose tolerance in diet-induced obese rats' more efficaciously than conventional doses of oral weight control agents sibutramine and rimonabant
    Larsen, Philip J.
    Lykkegaard, Kirsten
    Hansen, Gitte
    Knudsen, Lotte Bjerre
    DIABETES, 2006, 55 : A395 - A396
  • [45] One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial
    Pratley, R.
    Nauck, M.
    Bailey, T.
    Montanya, E.
    Cuddihy, R.
    Filetti, S.
    Garber, A.
    Thomsen, A. B.
    Hartvig, H.
    Davies, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (04) : 397 - 407